Casey Means's nomination for Surgeon General and her unexpected labor, the FDA's initiative to expedite approvals for cheaper biosimilar drugs, and Calley Means's departure from a White House advisory role highlight significant movements in government health leadership and drug accessibility.

• Casey Means, Surgeon General Nominee, Goes Into Labor Ahead of Senate Hearing — The New York Times Health -
• F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugs — The New York Times Health -
• R.F.K. Jr. Adviser Calley Means Has Left the White House — The New York Times Health -

A major study confirming text-based therapy's effectiveness in treating depression offers promising news for accessible mental health care, showing it performs as well as traditional video sessions.

• Study Finds Evidence That Text-Based Therapy Eases Depression — The New York Times Health -

The passing of Marthe Gautier, a key figure in the discovery of the genetic cause of Down Syndrome, reminds us of the profound impact of scientific pioneers and the struggle for recognition in medical history.

• Marthe Gautier, 96, Dies; Had Key Role in Down Syndrome Breakthrough — The New York Times Health -